Canaccord Genuity Initiates Actinium Pharmaceuticals At Buy By: Benzinga via Benzinga July 22, 2014 at 07:46 AM EDT Analysts at Canaccord Genuity initiated coverage on shares of Actinium Pharmaceuticals (NYSE: ATNM) with a Buy rating. The target ... Read More >> Related Stocks: Actinium Pharmaceuticals Inc